Indications for Lithium
Lithium is primarily indicated for the treatment of manic episodes in bipolar disorder and as a maintenance treatment to reduce the frequency and intensity of future episodes in patients with bipolar disorder. 1
Primary Indications
Acute manic episodes in bipolar disorder
Maintenance therapy in bipolar disorder
Secondary Indications
Suicide prevention
Bipolar depression
Special Populations
Pediatric bipolar disorder
- FDA-approved for bipolar disorder in youths aged 12 years and older 4
- Limited evidence from small studies but generally positive results 4
- Benefits demonstrated for comorbid substance abuse in adolescents 4
- Lower rates of relapse for adolescents with acute psychotic mania when combined with antipsychotics 4
Combination therapy
Monitoring Requirements
Baseline assessment before initiating lithium:
- Complete blood cell count
- Thyroid function tests
- Urinalysis
- Blood urea nitrogen, creatinine, and serum calcium levels
- Pregnancy test in female adolescents 4
Ongoing monitoring:
Important Considerations
Therapeutic window: Lithium has a narrow therapeutic index requiring careful dosing and monitoring 6
Discontinuation: Abrupt discontinuation can lead to withdrawal symptoms and rapid relapse; gradual tapering is recommended 5
Administration options: Single daily dosing may improve compliance and potentially reduce long-term renal damage compared to multiple daily dosing 6
Maintenance duration: Treatment should continue for at least 2 years after the last episode, with longer treatment often needed 5
Efficacy limitations: Less effective for rapid cycling patients and for preventing depressive episodes compared to manic episodes 2
Lithium remains a gold standard in bipolar disorder treatment despite the introduction of newer agents, with recent guidelines continuing to recommend it as a first-line mood stabilizer due to its established efficacy in both acute treatment and long-term prophylaxis 2, 7.